A healthy, athletic 17-year-old male was seen by his primary physician with complaints of the gradual onset of a lesion under his right great toenail. James H. Brien, DO It was described as beginning ...
At week 52, results showed that 65% of patients achieved mycologic cure. The Food and Drug Administration (FDA) has expanded the approval of Jublia® (efinaconazole; Bausch Health) topical solution to ...
Toenail changes often serve as early warning systems for underlying health conditions, with fungal infections representing one of the most common yet overlooked indicators of immune system function ...
TOPICA Pharmaceuticals, Inc., has announced positive results from its Phase 1/2a trial evaluating the safety, tolerability and pharmacokinetics of a 10% solution of luliconazole after maximal use ...
Medically reviewed by Danielle McNeil, D.P.M Key Takeaways Subungual onychomycosis is the most common type of toenail fungus ...
BROOKLYN, N.Y.--(BUSINESS WIRE)--Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first ...
LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics, an innovative biotech company, launched its first public investment campaign today to fund clinical trials of its Food and Drug Administration-cleared ...